Lipid Amine Nanoparticles for Stable Cellular Payload Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The delivery of biologically active payloads, such as nucleic acids and proteins, to cells is hindered by instability and low cell permeability, necessitating improved lipid nanoparticle compositions for targeted and safe delivery.
Innovation Solution
Development of lipid amine compounds with specific structural variations, including alkyl, alkenyl, and hydroxyalkyl chains, and heterocycloalkyl groups, which form lipid nanoparticle compositions for enhanced payload delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nucleic acids are delivered to cells using conventional methods, then the delivery process is simple, but the payloads exhibit low cell permeability and instability
Solution Approach 1:
The patent employs lipid nanoparticle compositions comprising multiple lipid components including ionizable lipids, phospholipids, and cholesterol in specific ratios to create a composite delivery system. This composite structure enhances payload stability and cell permeability while maintaining controlled complexity through defined compositional parameters
Solution Approach 2:
The invention optimizes delivery efficiency by systematically varying parameters including lipid chain lengths (C16-C24), degrees of unsaturation, headgroup compositions, and molar ratios of lipid components. These parameter adjustments enable tuning of nanoparticle properties to achieve optimal payload delivery while managing system complexity
2Reliability
If lipid nanoparticle compositions are developed with specific structural variations to improve delivery, then safety and efficacy are enhanced, but the compound structure and manufacturing become more complex
Solution Approach 1:
The patent introduces specific structural modifications at localized positions within lipid molecules, such as unsaturation at particular carbon positions (e.g., C9-C11), hydroxyl group placements, and headgroup variations. These localized quality changes enhance delivery performance while maintaining relatively simple overall molecular architectures that are amenable to synthesis
Solution Approach 2:
The invention systematically explores parameter variations including chain length (C16-C24), degree of unsaturation (0-2 double bonds), and headgroup types to optimize safety and efficacy. These parameter changes are implemented through modular synthetic approaches that balance structural complexity with manufacturability
3Ease of operation
If conventional delivery methods are used, then the process is straightforward, but the payloads suffer from instability and low cell permeability
Solution Approach 1:
The patent introduces lipid nanoparticle compositions as intermediary carriers that facilitate payload delivery. These nanoparticles serve as mediators between the payload and target cells, protecting payloads from degradation and enhancing cellular uptake through controlled interactions with cell membranes
Solution Approach 2:
The invention creates composite lipid nanoparticle systems combining multiple lipid types with complementary functions: ionizable lipids for endosomal escape, phospholipids for structural integrity, and cholesterol for membrane fluidity modulation. This composite approach enhances reliability while maintaining operational simplicity through standardized preparation protocols
Data Source
AI summary
Provided are lipid amine compounds which are useful in the preparation of lipid nanoparticle compositions for delivery of therapeutic or prophylactic payload into cells.